Hepatitis C: Silent Threat from Past Blood Transfusions

Every year, a small number of individuals in Ireland receive a life-altering diagnosis: they unknowingly contracted Hepatitis C through a blood transfusion received years, even decades, ago. Although significant advancements have been made in treatment, the legacy of contaminated blood products continues to impact lives, causing liver damage and, in some cases, cancer. This article explores the ongoing challenges faced by those affected, the history of the issue, and the available resources for support and treatment.

The Long Shadow of Past Infections

Hepatitis C is a virus that infects the liver, often causing no noticeable symptoms for many years. The Health Service Executive (HSE) explains that the only way to know if you have Hepatitis C is to get tested. If left untreated, the virus can lead to cirrhosis (scarring of the liver), liver cancer, and liver failure. The insidious nature of the disease means many individuals only discover their infection when they develop liver problems unrelated to their transfusion history.

A History of Screening and the Lookback Controversy

Testing for Hepatitis C became available in 1991. Still, a comprehensive “lookback” – a systematic search for individuals who had received potentially infected blood transfusions – was not implemented in Ireland. According to Susan Gaughran, head of Transfusion Positive, a support group for those affected, a lookback would have significantly improved outcomes by identifying infected individuals earlier. Professor Cliona O’Farrelly of Trinity College Dublin confirmed that a lookback was conducted for women who contracted Hepatitis C from the anti-D blood product, identifying 1,000 infections among 14,000 women screened, but this was not extended to all transfusion recipients.

The Human Cost: Stories of Loss and Resilience

The impact of Hepatitis C contracted through blood transfusions extends far beyond medical complications. Gerry O’Reilly shared the story of his mother, who received a transfusion in 1982 and was diagnosed with Hepatitis C in 2008. She later developed liver cancer and passed away six years after her diagnosis. “I’d love my mother to be around for that… to see that… but she’s not because she got infected [with Hepatitis C] in a State hospital,” O’Reilly stated.

Laura O’Brien, chair of Transfusion Positive, discovered she was Hepatitis C positive over 30 years ago. She faced not only the physical challenges of the illness but as well the stigma associated with it in the 1990s, experiencing social isolation and prejudice. Despite these hardships, O’Brien emphasized the importance of support networks like Transfusion Positive, which provided a lifeline for her and her family.

Current Treatment and Support

The excellent news is that Hepatitis C is now highly treatable. The HSE states that nearly all people with Hepatitis C can be cured with free treatment. However, many individuals may already have liver damage by the time they are diagnosed. Transfusion Positive provides medical and legal advice, as well as counseling, to those affected. The organization has seen its membership decrease from 300 to 180, reflecting both the success of treatment and the ongoing impact of the disease.

Ongoing Challenges and Future Directions

Despite improved treatment options and a strong relationship with the Irish Blood Transfusion Service (IBTS), challenges remain. A point of contention is the IBTS’s policy of not allowing individuals who have cleared the virus through treatment to donate blood. The IBTS maintains this stance due to the persistence of Hepatitis C antibodies in many treated patients, citing European regulations. Transfusion Positive continues to advocate for changes to this policy and for improved support for members, including addressing issues related to pension contributions for those who had to stop working due to their illness.

Key Takeaways

• Hepatitis C can be contracted through blood transfusions, even years after the transfusion occurred.
• Early diagnosis and treatment are crucial to prevent liver damage and cancer.
• Support groups like Transfusion Positive provide vital resources for those affected.
• While treatment is highly effective, ongoing challenges remain regarding blood donation eligibility and support for long-term complications.

Transfusion Positive remains dedicated to supporting those affected by Hepatitis C, offering a lifeline to individuals and families navigating the complexities of this often-silent disease. As treatment options continue to evolve, ongoing advocacy and awareness are essential to ensure that all those impacted receive the care and support they deserve.